
Sheheryar Kabraji
@skabrajimd
Assoc Prof | Chief of Breast Medicine @roswellpark | PI @KabrajiLab using #sysbio to study #quiescence #cancerdrugresistance
ID: 849464310699110400
https://www.roswellpark.org/sheheryar-kabraji 05-04-2017 03:30:48
1,1K Tweet
723 Followers
606 Following



Don't miss this study in JCI insight showing #Imlunestrant, a next-generation oral #SERD, overcoming #ESR1 mutant resistance in estrogen receptor-positive #BreastCancer. 🔓pubmed.ncbi.nlm.nih.gov/40327396/ Agostina Nardone Capucine Héraud Sheheryar Kabraji Sandro Santagata Sean Fanning Rinath Jeselsohn



3 grants submitted this month to support our effort 🎯 quiescent cancer cells in #bcsm! Great work Maia Homsi and Vittal Kurisetty! American Cancer Society National Cancer Institute Sheheryar Kabraji

Thanks for the invite to discuss the latest from #ASCO25 #bcsm Oncology Brothers ! Terrific discussion and questions

If you use Spearman (or Pearson) correlation p-values from standard software… there's a 99.9% chance they’re wrong. Drs. Han Yu and Alan Hutson oldbiostats of Roswell Park reveal why in "A robust Spearman correlation coefficient permutation test" , the top-cited article of the


To everyone riding in the Ride for Roswell today: Thank you for making a difference. Your impact is real, and we’re cheering you on every mile. 🎉🚴‍♂️ Have an incredible Ride! 💙, Our Team at Roswell Park



We did it — a record-breaking $6.1 million raised at the 30th annual Ride for Roswell! 🎉🚴‍♀️💙 Thank you to every rider, donor, volunteer, and supporter who made this incredible milestone happen. Read more: roswellpark.org/newsroom/20250…



Not enough people know how truly excellent the oncologist are Roswell Park — there’s an incredible legacy but every day we hear from patients who are being helped. World class// keep doing what you do.




Early Career Spotlight Session #4: Dr. Han Yu of Roswell Park (DRCC U24) presents an integrated machine learning-based prognostic model for head and neck cancer, focusing on the Systemic Inflammatory Response Index (SIRI) and its novel association with patient-reported financial


